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Abstract
Recent analysis of genetically modified mice deficient in different kainate receptor (KAR) subunits have strongly pointed to a
role of the GluK2 subunit, mediating the vulnerability of the brain towards seizures. Research concerning this issue has
focused mainly on the hippocampus. However, several studies point to a potential role of other parts of the hippocampal
formation, in particular the entorhinal cortex, in the development of epileptic seizures. There is extensive cell death after
such seizures in layer III of the medial entorhinal cortex (LIII mEC), making this region of special interest for investigation into
related pathological conditions. We therefore characterized KAR mediated currents in LIII mEC pyramidal neurons by several
different approaches. Using patch-clamp technique, in combination with glutamate uncaging in horizontal brain slices, we
show that LIII mEC neurons exhibit KAR currents. Use of genetically modified mice reveal that these currents are mediated
by GluK2 containing KARs. The IV curve indicates the predominant presence of a Ca2+ impermeable and edited form of the
KAR. Finally, we show that GluK2 containing kainate receptors are essential for kainate-induced gamma oscillations within
the entorhinal cortex.
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Introduction
Kainate receptors (KARs) have a wide functional spectrum,
ranging from the presynaptic regulation of transmitter release to
the postsynaptic generation of excitatory inward currents [1,2,3].
Furthermore, there is evidence indicating that they are also
involved in brain rhythmogenesis [4,5,6,7,8].
In contrast to alpha-amino-3-hydroxy-5-methyl-4-isoxazolepro-
pionic acid receptors (AMPARs), which have been studied
extensively, the roles and physiological importance of KARs are
less well understood, although they were originally cloned and
described over a decade ago [9,10,11,12] and for reviews see
[2,3,13]. One reason for this lack in our understanding of KAR
function is the limited availability of pharmacological agents that
enable KARs and AMPARs to be functionally distinguished. The
generation of different KAR specific knock-out (KO) mice
partially helped to overcome this drawback [14,15] and their
characterization yielded insights into KAR physiology. The recent
development of the AMPAR selective antagonists GYKI 52466
and GYKI 53655 has also considerably advanced research in the
KAR field.
One particular interesting aspect of KAR mediated action is the
ability of the KAR agonist kainate, which exhibits binding
preference for KARs, to evoke epileptic seizures following in vivo
administration in mice [16]. The interpretation that KAR
activation, rather than unspecific side effects due to activation of
other glutamate receptors, is responsible for this phenomenon is
supported by the fact that GluK2 KO mice have a much higher
threshold for the induction of epileptic seizures [14] as compared
to wild-type mice.
Epileptic seizures can also be evoked by electrical kindling of the
entorhinal cortex or the perforant path (which leads to antidromic
excitation of the entorhinal cortex, EC). For this reason, the EC is
a prime candidate region for the development of temporal lobe
epilepsy (TLE). The extensive interlaminar and intralaminar
connectivity of the EC provide an ideal anatomical network for the
generation of seizures [17]. Additionally, in the later stages of the
development of epilepsy, the EC is one of the first brain regions to
suffer from severe cell death. This holds especially true for LIII
mEC, making this region of special interest for investigation into
the related pathological conditions. Despite this, there has been
relatively little research into the basic features of KAR mediated
transmission in this region.
In this study we demonstrate the occurrence of KAR mediated
currents in LIII mEC pyramidal neurons. These currents are
conducted by GluK2 containing, Ca2+ impermeable receptors.
Methods
Slice preparation
Animal husbandry and experimental intervention were per-
formed according to the german animal welfare act and the
European Council Directive 86/609/EEC regarding the protection
of animals used for experimental and other scientific purposes. All
animal maintenance were performed in accordance with the
guidelines of local authorities, Berlin [T 0100/03]). Wistar rats
and C57/BL6 mice (2–3 weeks) were used for this study. The
GluK1 and GluK2 mice used in this study were raised on a C57/
BL6 background and littermate wildtype mice were used as control
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in such experiments. The animals were anaesthetized with
isoflurane, decapitated and brains were rapidly removed and placed
in ice-cold (4uC) oxygenated artificial cerebrospinal fluid (ACSF)
containing (in mM): NaCl (87), NaHCO3 (26), Sucrose (75),
Glucose (25), KCl (2.4), NaH2PO4 (1.25), MgCl2 (7), and CaCl2
(0.5), pH 7.4. Horizontal, combined entorhinal-hippocampal brain
slices (300 mm; 400 mm for oscillation experiments) were cut by
Leica VT 1200 Vibratome (Leica Microsystems, Wetzlar, Ger-
many). Slices were then incubated at 34–35uC for 30 minutes and
thereafter transferred to ACSF containing (in mM): NaCl (119),
NaHCO3 (26), Glucose (10), KCl (2.5), NaH2PO4 (1.25), MgCl2
(1.3), and CaCl2 (2.5), at room temperature or to an interface-type
recording chamber for oscillation experiments.. All ACSF solutions
were equilibrated with carbogen (95% O2 and 5% CO2).
Electrophysiological recordings
Prior to recording, slices were transferred to a submerged
recording chamber (Luigs and Neumann, Ratingen, Germany)
and perfused with oxygenated ACSF at room temperature, with a
perfusion rate of of 2.5–3.0 ml/min. Recording electrodes of 2–
3 MV resistance were pulled from borosilicate glass capillaries
(Harvard Apparatus, Kent, UK; 1.5 mm OD) using a micropi-
pette electrode puller (DMG Universal Puller). Biocytin (0.2%) was
included (for a subset of recorded cells) in the patch pipette to
assess the morphology and correct location of the recorded
neurons following the experiments. The internal solution for all
recordings included (in mM): K-gluconate (135), Hepes (10.0),
EGTA (0.5), KCl (20), MgATP (2.0) and Phosphocreatine (5.0),
with the exception of IV characterization, which included Cs-
gluconate (140), Hepes (10.0), EGTA (1.0), CaCl2 (0.5), and
Glucose (10.0).The osmolarities for the internal solutions were
300–305 mOsm, and the pH was adjusted to 7.2–7.3 with KOH
or CsOH. Whole-cell voltage and current-clamp recording of LIII
mEC pyramidal neurons were performed with an Axopatch 700A
Amplifier (Axon Instruments, Union City, CA, USA). Data were
acquired using a BNC-2090 adapter chassis, digitized (PCI 6035E
A/D Board, National Instruments, Austin, Texas) at 5–10 kHz
and recorded in IGOR Pro (WaveMetrics Inc., OR, USA).
Layer III mEC pyramidal neurons were initially recorded in the
current-clamp mode to identify them according to their charac-
teristic electroresponsive properties [18,19]. Identified neurons
were then held at 260 mV in voltage-clamp mode, and only
recordings from neurons whose series resistances ,30 MV were
used for data analysis.
The whole-cell holding current experiments were done in the
absence of any receptor-blockers unless mentioned otherwise on
the figures.
Excitatory postsynaptic currents (EPSCs) were evoked by
stimulating the layer I of the mEC (LI mEC). Synaptic KARs:
Evoked EPSCs were recorded until the amplitudes of the
responses were stable for a minimum of ten minutes before
control and experimental drug application responses were
obtained for analysis. EPSCKA were pharmacologically isolated
by adding 50 mM D(2)-2-amino-5-phosphonopentanoic acid
(APV), 2 mM Gabazine (SR 95531), 20 mM SCH 50911, (Tocris,
Ellisville, MO, USA), and 20 mM 1-(4-aminophenyl)-4-methyl-
7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride (GYKI
53655) to inhibit NMDA, GABA-A, GABA-B, and AMPA
receptors respectively. GYKI resistant EPSCs were blocked by
adding 25 mM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo(f)qui-
noxaline-7-sulfonamide (NBQX). A minimum of ten responses
were recorded under each condition and averaged for analysis.
Evoked EPSC amplitudes were calculated as the difference
between the averaged peak response and the average of the
baseline region (20 ms preceding the stimulus).
Glutamate uncaging: 20 ml of 200 mM MNI-caged-L-gluta-
mate (Tocris, Bristol, UK) were reperfused at 2.5–3.0 ml/min.
Uncaging was done using a UV pulsed laser (Rapp Optoelek-
tronik, Wedel, Germany) attached with a 200 mm optical fiber
coupled into the epifluorescence port of the microscope with an
OSI-BX adapter (Rapp Optoelektronik, Wedel, Germany) and
focused on the specimen by the objective lens. This yielded a
illuminated circle (20–50 mm) covering the whole somatodendritic
region of layer III cell bodies. The duration of the laser flash was
5 ms. The laser power under the objective corresponding to the
stimulus intensity levels used was monitored using a photo diode
array based photodetector (PDA-K-60, Rapp Optoelectronics,
Wedel, Germany) and did not change over time. Glutamate was
uncaged over the cell soma in the presence of all other channel
blockers as mentioned above. In combined experiments where
both the somatic and synaptic currents were recorded, first LI
mEC was stimulated with a stimulation electrode thus evoking a
synaptic response and after 200–300 ms, a laser pulse was flashed
to uncage MNI-glutamate evoking somatic current.
For studying gamma oscillations, slices were stored and recorded
from in the interface-type recording chamber. Extracellular
recording electrode was placed in the superficial layers of mEC
and baseline activity was recorded. Gamma oscillations were
induced by bath applying 300 nMKainic acid for upto 40 minutes.
Morphology
A subset of electrophysiologically characterized LIII mEC
pyramidal neurons were loaded with 0.2% biocytin and
reconstructed for visualization. Slices were fixed overnight in 4%
paraformaldehyde dissolved in 0.1 M sodium phosphate buffer
(PB, pH 7.4) and incubated for 24 hours in PB supplemented with
Avidin-coupled Alexa 488 (Invitrogen, Karlsruhe, Germany).
After washing with PB the slices were dehydrated with ethanol,
mounted on slides, and covered with DePeX (Serva, Heidelberg,
Germany). Confocal laser scanning images were taken using a
Leica TCS system (Bensheim, Germany).
Statistical treatments
All values in all graphs are presented as mean+/2SEM.
Analyses were performed using IGOR Pro (WaveMetrics Inc.,
OR, USA), SigmaPlot (SYSTAT, Hounslow, UK) and MATLAB
v7.0 (The Mathworks Inc., MA, USA). Statistical comparisons
between groups were performed with Student’s t-test. Results were
considered significant at p,0.05 or p,0.01 (*).
Drugs
Kainic acid, (Kainate, KA); 1-(4-aminophenyl)-4-methyl-7,8-
methylenedioxy-5H-2,3-benzodiazepine hydrochloride (GYKI
53655, henceforth in the manuscript GYKI would refer to GYKI
53655 unless mentioned otherwise); D(2)-2-amino-5-phosphono-
pentanoic acid (APV); 6-Imino-3-(4-methoxyphenyl)-1(6H)-pyri-
dazinebutanoic acid hydrobromide (Gabazine); (2S)-(+)-5,5-Di-
methyl-2-morpholineacetic acid (SCH 50911); 2,3-dioxo-6-nitro-
1,2,3,4-tetrahydrobenzo(f)quinoxaline-7-sulfonamide (NBQX) and
6-Chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiazi-
diazine-7-sulfonamide-1,1-dioxide (Cyclothiazide, CTZ) were all
purchased from Tocris Bioscience (Ellisville, MO, USA).
Results
The entorhinal cortex is a six-layered cortical structure (Layers
(L) I–V/VI; figure 1A) and the LIII mEC pyramidal neurons are
KAR Currents in mEC
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Figure 1. Layer III medial entorhinal cortex (LIII mEC) pyramidal neurons. (A) Schematic representation of the entorhinal-hippocampal
combined slice used in this study with the recording electrode (Recording) in LIII mEC while stimulating (Stimulation in LI mEC) the input from the
lateral entorhinal cortex. (B) Electrophysiological and morphological properties of a typical LIII mEC pyramidal neuron. (C) In situ hybridization of
GluK2 subunit of kainate receptor in the mEC. Data adapted from the Allen Atlas, Allen Institute of Brain Science.
doi:10.1371/journal.pone.0005576.g001
KAR Currents in mEC
PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5576
easily distinguishable from all other entorhinal neurons based on
anatomical location, morphology and characteristic electrophysi-
ological properties ([18,19], figure 1B). For this study we
performed whole cell recordings from these neurons (figure 1A –
experimental design). Furthermore, there is a mosaic like
distribution of kainate receptors in the mEC both in terms of
the subunit composition and layer-wise localization (figure 1C -
GluK2 subunit; Adapted from the Allen Atlas, Allen Institute of
Brain Science.), thereby offering an interesting prospect to study
KAR mediated currents in the LIII mEC pyramidal neurons.
Kainate concentration dependent changes in whole-cell
holding current of LIII mEC pyramidal neurons
KA activates non-NMDARs (AMPARs and KARs) with
different affinities. Low concentrations of KA (300 nM) activate
only KARs while at higher concentrations (1 mM) it acts as an
agonist for both AMPARs and KARs [14].
Concentration dependent successive activation of non-NMDARs
leads to conductance changes of the cell, reflected in corresponding
changes in its holding current. After attaining whole-cell configu-
ration (at 260 mV) a baseline of holding current was obtained,
following which increasing concentrations (100 nM, 300 nM, 1 mM
and 3 mM) of KA were bath applied for five minutes each. Further
increase of KA leads to severely depolarized cells and unstable
recordings and was therefore omitted. The changes in holding
current (figure 2A - single cell with voltage-clamp transients
corresponding to baseline, 300 nM, 3 mM and NBQX; 2B - group
data, n= 6) at the end of the five minute KA bath application were
53.54613.95 pA at 100 nM, 131.79618.98 pA at 300 nM,
201.64620.55 pA at 1 mM and 303.58633.25 pA at 3 mM. The
KA-induced holding current change was reduced after washing in
25 mM NBQX, indicating that non-NMDARs were involved.
KAR mediated currents in LIII mEC pyramidal neurons
To study KAR mediated currents in LIII mEC pyramidal
neurons it is necessary to isolate this current from the combined
current mediated by AMPARs and KARs. Since KA activates
both AMPARs and KARs at different concentrations, it was
necessary for us to determine the particular KA concentration at
which only KARs are activated. Inititially, two different KA
concentrations (300 nM and 1 mM) were applied subsequently
followed by GYKI (20 mM) while monitoring holding current
changes (figure 2C). Since GYKI showed an effect on the holding
current following the 1 mM KA wash-in, it suggested that at this
concentration AMPARs are activated along with KARs. This is
summarized below and in figure 2F. Therefore, to isolate a pure
KAR-mediated change in holding current, only the lower
concentration of 300 nM KA was bath applied in separate
experiments. The holding current changed by 181.58623.83 pA,
following washout of KA, 20 mMGYKI was applied for 5 minutes
and then 300 nM KA was reapplied (figure 2D–E, n= 4). On
applying 300 nM KA for the second time, the holding current
changed by 174620.7 pA. Since the changes in holding current in
the absence and presence of AMPA receptor blocker, GYKI was
not significiantly different, these changes are therefore mediated
predominantly by KARs (figure 2F, n= 4). At 1 mM KA,
substantial amount of AMPARs were activated as there was a
significant difference in holding current before (229.3634.5 pA)
and after (130.9638.8 pA) washing in GYKI (figure 2F, n = 4).
Since at 1 mM KA, AMPA receptors were also activated along
with KARs, 300 nM KA was chosen as the working concentration
which activated only KARs and no AMPA receptors for LIII mEC
pyramidal neurons.
KAR-mediated currents were also analysed in LII mEC stellate
neurons. We found smaller holding current changes following
application of 300 nM KA, in the presence of GYKI, in stellate
cells (108.8615.4, n= 7) in comparison to pyramidal neurons
(1746.20.7, n = 4) in layer III (figure S1B). However, this could be
due to differences in membrane capacitance. Indeed, stellate cells
have a smaller capacitance in comparison to layer III pyramidal
neurons [20]. In a small number of neurons we analysed the
current densities between the two neuronal populations, but could
not detect any siginificant difference (LII stellate: 0.6360.17 pA/
pF; LIII pyramidal neurons: 0.7560.08 pA/pF; p = 0.57; n= 3 for
each cell type).
GluK2 is the major subunit mediating the KAR current in
LIII mEC pyramidal neurons
KARs have different expression patterns at different synapses
and also the composition of subunits vary. In order to determine
the role of GluK1 and GluK2 subunit in the KAR mediated
current in the LIII mEC neurons, GluK1 and GluK2 KO mice
were used. By bath applying 300 nM KA, the holding current in
the GluK1 KO changed by 118.13619.73 pA which was not
significantly altered (p=0.181) when compared to the changes
observed in wild-type mice (86.8267.4 pA, n = 4 each for GluK1
KO and WT). However, in the GluK2 KO there was no change in
holding current over the whole duration of bath application of
300 nM KA (figure 3A – single cell data; 3B – group data, n = 9
for GluK2 KO). This suggests that GluK2 is the major subunit
mediating the KAR currents in the LIII mEC pyramidal neurons.
Characterization of the KARs
RNA editing (Q/R editing) of KARs influences channel
properties. The unedited form of the receptor with glutamine
(Q) at the Q/R site renders the channel permeable to Ca2+
whereas the edited form of the receptor with the positively charged
arginine (R) makes it Ca2+ impermeable [21,22,23]. To determine
whether the KARs present on the LIII mEC pyramidal neurons
were of the edited or non-edited form, an IV curve was computed
by uncaging 200 mM MNI-Glutamate over the cell soma in the
presence of 100 mM APV, 2 mM Gabazine and 20 mM GYKI
(figure 4C–D). Initially the cell was held at260 mV and a baseline
of stable responses (20 to 25 sweeps, pulse of 5 ms duration at an
inter-stimulus interval of 30 seconds) was obtained in the presence
of ACSF containing APV and Gabazine only. After washing in
GYKI, the isolated KAR current was 34.32% (62.05%) of the
baseline value (figure 4A, n= 5). This remaining current in GYKI
were mediated by KARs because they were blocked completely by
NBQX (25 mM; data not shown).
For the IV curve of the KARs, the holding membrane potential
was changed in steps of 20 mV from 260 mV to 40 mV and at
each step, five responses were recorded. Posthoc analysis was
performed by averaging these five responses. Calculated junction
potential of 10 mV was subtracted from the holding membrane
potential. A linear relationship between voltage and current, both
at negative and positive potentials (figure 4C–D, n= 7) suggested
the KARs on LIII mEC pyramidal neurons to consist mostly of the
Ca2+ impermeable edited form. To prove that the IV curve was
for purely KAR mediated responses, at the end of each
experiment, cells were brought back to a holding membrane
potential of 260 mV and either 10 or 100 mM Cyclothiazide
(CTZ) was added. There was no potentiation of the response on
washing in 10 mM CTZ proving that there was no contribution of
AMPARs. However, at a higher CTZ concentration (100 mM),
the drug antagonizes GYKI [24] and therefore a large
potentiation of AMPARs was seen in this case (figure 4B, n = 4
KAR Currents in mEC
PLoS ONE | www.plosone.org 4 May 2009 | Volume 4 | Issue 5 | e5576
Figure 2. Kainate (KA) induced changes in whole-cell holding current and activation threshold of kainate receptors (KARs) on LIII
mEC pyramidal neurons. (A, B) Time course data for KA (100 nM, 300 nM, 1 mM and 3 mM) induced concentration dependent changes in the
whole-cell holding current which is antagonized by NBQX (25 mM). (A) Single experiment with voltage-clamp transients corresponding to baseline,
300 nM, 3 mM and NBQX. (B) Group data (n = 6). (C) Time course data from a single experiment for two different KA concentrations (300 nM and
1 mM) with subsequent application of GYKI (20 mM) and NBQX (25 mM). (D, E) Time course data for determining the activation threshold of kainate
receptors on LIII mEC pyramidal neurons. The change in the whole-cell holding current by bath application of 300 nM of KA was reversible and
following treatment with GYKI (20 mM), 300 nM KA was applied for a second time. Holding current decreased to the same amplitude indicating that
at a concentration of 300 nM KA, no AMPA receptors are activated. (D) Single experiment. (E) Group data (n = 4). (F) While there is no effect of GYKI
(20 mM) on holding current at 300 nM KA (p= 0.344; n = 4) there is a significant effect at 1 mM KA (p,0.05; n = 4).
doi:10.1371/journal.pone.0005576.g002
KAR Currents in mEC
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and 6 for 10 mM and 100 mM CTZ respectively). In separate
experiments, 10 mMCTZ was added to mixed AMPAR and KAR
responses and this concentration was sufficient to potentiate any
existing AMPAR component in the response (data not shown).
Synaptic activation of KARs
To investigate the contribution of synaptic KARs to the
observed currents, recorded LIII mEC pyramidal neurons in the
whole-cell mode were stimulated by placing a stimulation
electrode in LI mEC. In this region, the distal apical dendrites
of the LIII mEC pyramidal neurons synapse onto the input
pathways from the lateral EC. Baseline EPSCAMPA+KA was
recorded in the presence of ACSF containing 50 mM APV,
2 mM Gabazine and 20 mM SCH 50911. After a stable baseline
response, 20 mM GYKI was washed in to isolate EPSCKA
(figure 5A, n= 8). The EPSC was blocked in GYKI. Since there
was no EPSCKA in the recorded neurons, the apparent conclusion
was that there were no synaptic KARs activated upon stimulation
of this pathway. To verify this finding high frequency stimulations
(5 pulses at 200 Hz, 10 pulses at 200 Hz, 5 pulses at 25 Hz and 10
pulses at 25 Hz; [25] were performed in the presence of GYKI.
There was no detectable EPSCKA under these stimulation
conditions indicating the absence of synaptic KARs in the distal
dendritic region (figure 5B).
In a further experiment, synaptic stimulation in LI mEC was
combined with glutamate uncaging, thereby recording first a
synaptic current and thereafter a somatic current from the same
cell while all other conditions remained constant. After washing in
GYKI, the somatic current was reduced to 30.96%64.45% of the
baseline value while the synaptic current was blocked (data not
shown).
Our data suggests that there is negligible contribution of
synaptic KARs upon stimulating LI mEC. However, a KAR
current was evoked by uncaging glutamate over the cell soma
indicating that the functional KARs could be limited to the
somatodendritic region of LIII mEC pyramidal neurons. It has
been shown that the distribution of KARs can be pathway specific
[25,26]. To determine, whether any other input pathway would
yield a significantly higher proportion of synaptic KAR mediated
current, we stimulated at the border of LII–III mEC. When
kainate currents were isolated in the presence of GYKI, a GYKI
resistant component was seen (10.24%61.1% of baseline), which
was blocked by NBQX (figure 5C, n= 5). Thus by stimulating a
different pathway, a EPSCKA could be evoked in LIII mEC
pyramidal neurons. In an additional experiment, the stimulation
electrode was first placed in LI mEC, thereby evoking no
EPSCKA. However, relocating the electrode within the same
experiment to a second position at the border of LII–III mEC
without increasing the stimulation intensity, EPSCKA was evoked
in the same cell (14.31%64.7% of baseline; data not shown).
Taken together, the data suggests the presence of KARs limited
to the somatodendritic region of LIII mEC pyramidal neurons
(somatic uncaging and LII–III stimulation) and a clear lack of
KARs in the distal dendrites.
Role of GluK2 in network synchrony
Oscillations in the gamma frequency are recordable from the
entorhinal cortex in humans and rodents. It was recently shown
that the medial entorhinal cortex (mEC) in isolation in vitro
generates gamma frequency oscillations in response to kainate
receptor agonists [4]. Importantly, these kainate-induced oscilla-
tions in vitro had the same horizontal and laminar spatiotemporal
distribution as seen in vivo.
We observed during whole-cell patch-clamp recordings from
LIII mEC pyramidal neurons, rhythmic postsynaptic currents
following the application of low doses of kainate. Figure 6A1 shows
an example in which under baseline conditions little spontaneous
activity was recorded. However, following the application of
300 nM KA a massive increase in spontaneous postsynaptic
currents was observed, which had a frequency content of about
10–12 Hz (Figure 6A1, n= 7). In comparison such a synchronised
increase in spontaneous postsynaptic currents was absent in the
GluK2 KO mice upon bath applying KA (fig 6A2, n = 7).
Next, we made local field potential recordings within the
superficial layers of the entorhinal cortex. These recordings were
done in an interface chamber, a condition which improves the
reliability and enhances the power of network oscillations. Low
concentrations of kainate (300 nM), indeed, induced robust
oscillations. Power spectra analysis revealed a major peak
frequency of 40 Hz (fig 6B1, n = 8 slices). The kainate-induced
oscillations in the entorhinal cortex were blocked by the KAR/
Figure 3. Genetic deletion studies to determine the role of
GluK1 and GluK2 subunits in the KAR mediated current on the
LIII mEC pyramidal neurons. (A, B) By bath applying 300 nM KA,
the holding current in the GluK1 KO did not change significantly when
compared to the wild-type mice (p=0.181; n = 4). However, no change
in holding current was observed for GluK2 KO (n = 9) upon bath
applying 300 nM KA indicating that the GluK2 is the predominant KAR
subunit responsible for mediating the observed KAR current in these
neurons. (A) Single experiment. (B) Group data.
doi:10.1371/journal.pone.0005576.g003
KAR Currents in mEC
PLoS ONE | www.plosone.org 6 May 2009 | Volume 4 | Issue 5 | e5576
AMPAR-antagonist NBQX. Further, we again made use of the
GluK2 KO mice. Figure 6B2 (n= 7 slices) shows that the kainate-
induced oscillations were completely abolished in the genetic
deletion model.
Discussion
This study focuses on the layer III of the medial entorhinal
cortex, which provides input to the hippocampal CA1 region and
subiculum via the perforant path. Since this particular layer suffers
from extensive neuronal cell death after epileptic seizures
[27,28,29,30], characterization of its synaptic connectivity and
modes of synaptic transmission are of critical interest. We show
that KAR mediated currents could be evoked in LIII mEC
pyramidal neurons. These currents possess properties of Ca2+
impermeable KARs and were mediated by GluK2 containing
receptors.
KARs can be localized both post- and pre-synaptically.
Postsynaptically they facilitate synaptic currents and influence
signal integration [31]. Presynaptically they regulate transmission,
e.g. by decreasing the probability of transmitter release. Bath
application of KA evoked a reversible increase in the holding
Figure 4. IV curve and characterization of kainate receptors on LIII mEC pyramidal neurons using photolytic uncaging of
glutamate. (A) Photolytic uncaging of glutamate at the cell soma elicited inward currents, which were reduced to 34.32% (62.05%; p,0.01; n = 5)
of the baseline value in the presence of GYKI (20 mM). (B) At 20 mM of GYKI no residual AMPA current is seen as there is no potentiation of the
resultant EPSC upon application of AMPAR desensitization blocker CTZ (10 mM; p= 0.956; n = 4). However, at a higher concentration of CTZ (100 mM),
the effect of GYKI is antagonized (p,0.01; n = 6). In the presence of GYKI, APV and Gabazine, the holding membrane potential was changed in steps
of 20 mV from 260 mV to 40 mV and at each step, 5 responses (5 laser flashes with a inter-stimulus interval of 30 seconds) were recorded by
uncaging glutamate over the cell soma. (C) The peak current for each individual cell (n = 7) is plotted against the membrane potential along with the
corresponding superimposed current traces (inset). (D) Group data (n = 7). A linear relationship between voltage and current, both at negative and
positive potentials suggested the KARs on LIII mEC pyramidal neurons to be mostly of the Ca2+ impermeable edited form.
doi:10.1371/journal.pone.0005576.g004
KAR Currents in mEC
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current, which could also be observed in the presence of the
specific AMPAR blocker GYKI 53655, indicating a KAR
mediated effect. We determined that at a concentration of
300 nM KA, KARs are selectively activated. Although the subunit
composition of individual KARs is not completely clear, ionotropic
KARs often include either GluK1 or GluK2 subunits [2,3,13,32].
Using genetically modified mice lacking either GluK1 or GluK2,
we have shown unambiguously that GluK2 and not GluK1
subunit contribute to the recorded KAR currents. Since there is
considerable presence of transcripts of other kainate receptor
subunits (GluK3, GluK4 and GluK5; [12,33]), one cannot exclude
the contribution of heteromeric GluK2 KARs towards the
observed kainate current.
Laser mediated glutamate uncaging in the somatic region of
LIII mEC pyramidal neurons reliably produced KAR mediated
currents in the presence of GYKI and were blocked by the
application of NBQX. Additional evidence that these current was
mediated exclusively by KAR was provided by the fact that the
remaining current was unaltered during application of the
AMPAR desensitization blocker CTZ.
The AMPAR subunit GluA2 as well as the KAR subunits
GluK1 and GluK2 can undergo Q/R editing, a process
determining the calcium permeability, rectification and conduc-
tance of the ion channels [21,22,23]. Whereas GluA2 editing
seems to be almost complete in the adult animal, and disruption of
the editing process is lethal [34,35], KAR editing increases only to
a degree of 60–80% during development [21,22,23] and
interfering with GluK1 editing showed only a mild phenotype
[36]. On the other hand, analysis of mutant mice which do not
undergo GluK2 editing show NMDAR independent LTP at the
EC-DG synapse as well as an increased vulnerability to seizures
[37], arguing for a developmental need to down regulate the
unedited Ca2+ permeable GluK2 receptors and replace them by
edited ones.
These considerations, together with the potential role of the EC
in epilepsy led us to investigate whether the dominating
Figure 5. Pathway specific activation of synaptic KARs in LIII mEC pyramidal neurons. (A, B) Recorded LIII mEC pyramidal neurons were
held in the whole-cell mode while stimulating the afferent pathway LI mEC. (A, lower panel) In the presence of GYKI (20 mM), no synaptically
evoked EPSCKA is detected (n = 8) as seen in an example trace from a single experiment. (B) High frequency stimulations (5 pulses at 25 Hz, 10 pulses
at 25 Hz, 5 pulses at 200 Hz and 10 pulses at 200 Hz) were performed in the presence of GYKI. There was no detectable EPSCKA under these
stimulation conditions as well indicating the absence of synaptic KARs upon stimulation of this pathway. (C) To determine, whether any other input
pathway would yield a significantly higher proportion of synaptic KAR mediated current, we stimulated at the border of LII–III mEC. In the presence of
GYKI, an EPSCKA was observed (10.24%61.1% of baseline; n = 5) as seen in an example trace from a single experiment (C, lower panel). Thus by
stimulating a different pathway, a EPSCKA could be evoked on LIII mEC pyramidal neurons, suggesting the existence of synaptic KARs in a pathway
specific manner.
doi:10.1371/journal.pone.0005576.g005
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electrophysiological phenotype of LIII mEC pyramidal neurons is
of the unedited, rectifying and Ca2+ permeable form or not.
It turned out that the majority of these channels consist of non-
rectifying channels, suggesting that the critical receptor subunit is
of the edited form. As a functional consequence, a large proportion
of these receptors are Ca2+ impermeable. Although not very much
is known about the physiological role especially of KAR Q/R
editing [23], they might play a role in certain pathologic
conditions. For example, abnormalities in the ratio of the
unedited/edited forms have been reported as a consequence of
ischemia [38]. Furthermore, analysis of AMPAR and KAR editing
ratio in epileptic patients revealed differences in various brain
regions, suggesting a possible involvement of the editing process in
this disease [39,40,41,42]. It would be of interest to investigate a
potential role of GluK2 editing in the developmental course of
epilepsy in the EC.
We tried to evoke synaptic KAR mediated responses by
stimulating the inputs from the lateral EC by placing a stimulation
Figure 6. Role of GluK2 in network synchrony. (A1) Rhythmic postsynaptic currents were recorded from WT mice (n = 7) following the
application of 300 nM KA which had a frequency content of about 10–12 Hz. (A2) In comparison such a synchronised increase in spontaneous
postsynaptic currents was absent in the GluK2 KO mice (n = 7). (B1, B2) Local field potential recordings within the superficial layers of the entorhinal
cortex were done in an interphase chamber to record KA-induced gamma oscillations. (B1) Low concentrations of KA (300 nM) induced robust
oscillations (n = 8 slices). Power spectra analysis revealed a major peak frequency of 40 Hz. The KA-induced gamma oscillations were blocked by the
KAR/AMPAR-antagonist NBQX. (B2) Gamma oscillations were completely abolished in the GluK2 KO mice (n = 7 slices).
doi:10.1371/journal.pone.0005576.g006
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electrode in LI mEC. Although we could reliably evoke AMPAR
mediated synaptic transmission, which confirmed intact connectiv-
ity in our working stimulation conditions, no detectable synaptic
current was found after blocking AMPAR mediated currents with
GYKI. This argues against synaptically localized KARs, at least in
the distal apical dendrite of layer III cells. A similar phenomenon
was observed by [25], showing little synaptic transmission after
blockade of AMPAR mediated transmission at mossy fibre synapses
in the CA3 region of the hippocampus. However, short high
frequency stimulation during AMPAR blockade (in the presence of
GYKI) in this study lead to a potentiation of the KAR mediated
currents. One possible interpretation of these results would be the
existence of extrasynaptic KARs that could only be activated by
glutamate spillover resulting from synchronous activation of
excitatory fibres. To test whether this scenario also holds true for
the layer I input to the layer III mEC cells, several similar high
frequency protocols were applied. There was no detectable KAR
mediated current observed in any case. The most straightforward
interpretation of these results is that the distal apical dendrite of
layer III cells is devoid of KARs. Also recently, astrocytic glutamate
release has been implicated in extrasynaptic activation of neuronal
KAR [43], offering a potential explanation and functional role for
these receptors, in addition to activation via spillover of synaptically
released glutamate after intense stimulation.
However, moving the stimulation electrode to the LII–III
border reliably yielded synaptic responses in the presence of
GYKI. Based on these results, we conclude that LIII mEC has
functional KARs that contain GluK2 and are restricted to the
somatodendritic region of the pyramidal neurons in this layer.
Recent studies [44,45] show that LIII mEC neurons show small
but significant residual synaptic currents after blocking AMPAR
mediated currents via the application of 100 mM GYKI 52466 by
stimulating at the border of LII–III. These responses could be
potentiated by brief high frequency stimulation. The present study
confirms one of the results obtained there, namely the existence of
KAR mediated synaptic currents evoked by LII–III stimulation.
Furthermore we extend their findings by identifying the
responsible KAR subunit involved, no synaptic KAR current
upon LI stimulation and that a KAR current is evoked upon
stimulating at the border of LII–III mEC.
We have shown that GluK2 containing KAR-mediated synaptic
currents are exclusively restricted to the somatodendritic region of
LIII mEC pyramidal neurons, where they are most likely boosting
excitatory synaptic transmission, as reported for other synapses
[31]. Furthermore, there is connectivity between superficial and
deeper layers and within layer III itself [17]. Also LIII mEC
neurons project via the perforant path to the CA1 and Subiculum
region. Boosting and prolonging the influx of positive charges
during stimulation might be an important mechanism influencing
the time window required to form long term association between
different inputs arriving in this region. The observed localization
of KAR mediated currents might also be an explanation for the
almost complete loss of LIII mEC pyramidal neurons, often
observed in experimental models of epilepsy.
Changes in the power of gamma oscillations have been reported
to occur in animal models of psychiatric diseases [5]. Although this
is a purely correlative observation, it is interesting to note that
these alterations occurred exclusively in the entorhinal cortex and
not in the hippocampus. In addition oscillatory behaviour in
neuronal circuits might be related to cognitive performance and
pathological mental states [46], as suggested by the action of
several clinically used drugs. The idea of involvement of KAR in
cognitive processes is furthermore supported by genetic studies
which have identified mutations in GluK2 as a potential cause for
mental retardation [47].
Analysing the cellular and subcellular distribution and proper-
ties of these receptors and investigating their functional role in
network behaviour such as oscillations will therefore most
probably provide insights into underlying physiological mecha-
nisms of cortical and cognitive function and their pathophysiolgo-
gical alterations.
Supporting Information
Figure S1 Kainate (KA) induced changes in whole-cell holding
current of KARs on LII mEC stellate neurons. (A) Electrophys-
iological and morphological properties of a typical LII mEC
stellate neuron. (B) Upon application of 300 nM KA, LII stellate
neurons (n = 7) depolarised to a significantly lesser degree as
compared to LIII pyramidal neurons (p,0.01; n= 4). (C) Time
course data from a single experiment of the whole-cell holding
current of a LII stellate neuron upon bath application of 300 nM
of KA in the presence of GYKI (20 mM).
Found at: doi:10.1371/journal.pone.0005576.s001 (0.63 MB TIF)
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